Related Experiment Video
Updated: Apr 6, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Variable Phenotype of Diabetes Mellitus in Siblings with a Homozygous PTF1A Enhancer Mutation
E Nazlı Gonc1, Alev Ozon, Ayfer Alikasifoglu
1Department of Pediatric Endocrinology, Hacettepe University, Ankara, Turkey.
Insights
PTF1A enhancer mutations can cause neonatal diabetes and pancreatic agenesis. This study details two siblings with these mutations, showing varied diabetes severity and onset ages.
Area of Science:
- Endocrinology
- Genetics
- Developmental Biology
Background:
- Neonatal diabetes mellitus (NDM) is a rare condition with onset within the first six months of life.
- Pancreas agenesis, a congenital absence of the pancreas, is a known cause of NDM.
- PTF1A enhancer mutations have recently been identified as a cause of NDM linked to pancreatic agenesis.
Observation:
- This report describes two siblings carrying PTF1A enhancer mutations.
- One sibling presented with neonatal diabetes mellitus.
- The elder sister exhibited a milder form of diabetes, with onset at nine years of age.
Findings:
- PTF1A enhancer mutations are associated with a spectrum of diabetes phenotypes.
- The severity and age of onset of diabetes can vary even within the same family for PTF1A-related conditions.
- This highlights the complex genetic and phenotypic variability in pancreatic development disorders.
Implications:
- Understanding PTF1A mutations deepens insights into pancreatic development and diabetes etiology.
- This genetic information can aid in diagnosing and counseling families affected by NDM and related disorders.
- Further research into PTF1A's role may reveal novel therapeutic targets for diabetes and pancreatic insufficiency.
Abstract:
Neonatal diabetes is a rare form of diabetes, characterized by onset in the first 6 months of life. A number of cases are due to pancreas agenesis. Recently, PTF1A enhancer mutations have been shown to cause neonatal diabetes associated with pancreatic agenesis. Herein, we report the clinical features of two siblings with PTF1A enhancer mutations, one of whom had neonatal diabetes, whereas the elder sister had a milder form of the disease with onset of diabetes at 9 years of age.
Related Concept Videos
Incomplete Dominance
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Genetic Lingo
Pedigree Analysis
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Cell Specific Gene Expression

